News
2h
Zacks Investment Research on MSNThermo Fisher (TMO) Q2 Earnings Preview: What You Should Know Beyond the Headline EstimatesAnalysts on Wall Street project that Thermo Fisher Scientific (TMO) will announce quarterly earnings of $5.22 per share in its forthcoming report, representing a decline of 2.8% year over year.
3h
Zacks Investment Research on MSNTMO to Report Q2 Earnings: Analytical Instruments Segment in FocusThermo Fisher Scientific Inc. TMO is slated to release second-quarter 2025 results on July 23, before market open. Thermo Fisher’s first-quarter earnings of $5.15 per share beat the Zacks Consensus ...
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...
The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of ...
BigCommerce to Announce Second Quarter 2025 Financial Results on July 31, 2025 Provided by GlobeNewswire Jul 2, 2025, 1:30:00 PM ...
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2025 after the market close on Wednesday, July 30, 2025.
Beta Bionics plans to announce Q2 2025 financial results on July 29, followed by a conference call.
Moderna’s new influenza vaccine, based on the same mRNA technology used in its COVID-19 vaccine, showed promising results in a major trial.
TUESDAY, July 1, 2025 (HealthDay News) — Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced Monday ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results